SCYX — Scynexis Income Statement
0.000.00%
Last trade - 00:00
- $80.47m
- $12.62m
- $140.14m
- 63
- 98
- 74
- 93
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.121 | 0 | 13.2 | 5.09 | 140 |
Cost of Revenue | |||||
Gross Profit | — | — | 12.9 | 4.46 | 125 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 50.1 | 52.9 | 76.7 | 90.8 | 67.5 |
Operating Profit | -50 | -52.9 | -63.6 | -85.8 | 72.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -53.7 | -58.3 | -36 | -67.5 | 67.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -53.7 | -55.2 | -32.9 | -62.8 | 67 |
Net Income Before Extraordinary Items | |||||
Net Income | -53.7 | -55.2 | -32.9 | -62.8 | 67 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -53.7 | -55.2 | -32.9 | -62.8 | 67 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -9.39 | -5.04 | -1.18 | -1.47 | 1.39 |